005690.KS

Pharmicell Co., Ltd. [005690.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

005690.KS Stock Summary

Top 005690.KS Correlated Resources

005690.KS


Top 10 Correlated ETFs

005690.KS


Top 10 Correlated Stocks

005690.KS


In the News

005690.KS Financial details

Company Rating
Buy
Market Cap
622.24B
Income
12.91B
Revenue
60.05B
Book val./share
1383.54
Cash/share
477.38
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
06 Feb 2023
P/E
48.95
Forward P/E
-
PEG
3.32
P/S
10.52
P/B
7.66
P/C
22.2
P/FCF
-27.33
Quick Ratio
1.14
Current Ratio
2.67
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
215.2
EPS next Y
-
EPS next Q
-
EPS this Y
82.41%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
15.1%
Revenue Q/Q
27.13%
EPS Q/Q
75.68%
-
-
-
-
SMA20
-5.37%
SMA50
0.45%
SMA100
-14.82%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
17%
ROC
0.1%
Gross Margin
42%
Oper. Margin
15%
Profit Margin
21%
Payout
-
Shs Outstand
60M
Shs Float
39.8M
-
-
-
-
Target Price
-
52W Range
8570.0-16450.0
52W High
-35.56%
52W Low
+23.69%
RSI
51.29
Rel Volume
0.38
Avg Volume
450.05K
Volume
172.66K
Perf Week
3.92%
Perf Month
-7.83%
Perf Quarter
-22.34%
Perf Half Y
-9.01%
-
-
-
-
Beta
-0.811703
-
-
Volatility
137.81%, 472.42%
Prev Close
-0.93%
Price
10600
Change
-1.4%

005690.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
431.52477.57541.85629.77848.99
Net income per share
-671.27-213.672.5287.44158.7
Operating cash flow per share
-34.3857.36-1.26149.77-87.12
Free cash flow per share
-107.56-21.43-28.99137.38-159.18
Cash per share
228.69347.89313.59432.89604.61
Book value per share
958.92799.94859.43952.611.09K
Tangible book value per share
578.29686.57741.71847.43986.17
Share holders equity per share
958.92799.94859.43952.611.09K
Interest debt per share
6.7851.4953.0752.56315.8
Market cap
376.63B1021.11B481.97B863.22B611.45B
Enterprise value
364.01B1005.52B468.34B845.35B602.49B
P/E ratio
-9.61-80.52110.87164.6864.27
Price to sales ratio
14.9536.0214.8422.8712.01
POCF ratio
-187.63299.89-6.38K96.15-117.09
PFCF ratio
-59.97-802.51-277.35104.82-64.08
P/B Ratio
6.7321.59.3615.129.36
PTB ratio
6.7321.59.3615.129.36
EV to sales
14.4535.4714.4222.3911.84
Enterprise value over EBITDA
-10.15-91.4108.01119.1346.59
EV to operating cash flow
-181.34295.31-6.2K94.16-115.37
EV to free cash flow
-57.96-790.26-269.51102.65-63.14
Earnings yield
-0.1-0.010.010.010.02
Free cash flow yield
-0.02000.01-0.02
Debt to equity
0.010.06000
Debt to assets
0.120.20.190.180.32
Net debt to EBITDA
0.351.42-3.14-2.52-0.69
Current ratio
10.869.796.276.62.67
Interest coverage
04.5819.3885.214.52
Income quality
0.05-0.27-0.021.71-0.55
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.020.020.010.010.01
Research and developement to revenue
0.140.160.150.110.14
Intangibles to total assets
0.350.110.110.090.07
Capex to operating cash flow
2.13-1.3722.02-0.080.83
Capex to revenue
-0.17-0.16-0.05-0.02-0.08
Capex to depreciation
-1.28-2.88-0.93-0.42-2.49
Stock based compensation to revenue
00000
Graham number
3.81K1.96K1.18K1.37K1.97K
ROIC
-0.0700.030.110.11
Return on tangible assets
-0.94-0.240.080.080.11
Graham Net
142.4197.31186.25274.92237.34
Working capital
23.47B29.21B29.13B36.43B41.58B
Tangible asset value
33.77B40.76B44.46B50.8B59.12B
Net current asset value
18.09B20.91B22.91B30.3B36.06B
Invested capital
0.010.060.060.050.26
Average receivables
00000
Average payables
1.35B1.52B1.29B1.97B1.4B
Average inventory
5.89B5.86B7.28B6.34B11.61B
Days sales outstanding
00000
Days payables outstanding
15.3223.4711.2636.0411.14
Days of inventory on hand
115.91118.57154.37115.83224.7
Receivables turnover
00000
Payables turnover
23.8315.5532.4110.1332.75
Inventory turnover
3.153.082.363.151.62
ROE
-0.7-0.270.080.090.15
Capex per share
-73.18-78.79-27.73-12.39-72.07

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
219.78196.8289.74224.85289.5
Net income per share
59.6431.2823765
Operating cash flow per share
60.35-188.5977.67-4.656.29
Free cash flow per share
48.07-207.6229.84-79.7-128.45
Cash per share
815.79604.61636.18586.72477.38
Book value per share
1.08K1.09K1.24K1.3K1.38K
Tangible book value per share
952.78986.171.14K1.2K1.28K
Share holders equity per share
1.08K1.09K1.24K1.3K1.38K
Interest debt per share
287.52300.38313.13294.85316.93
Market cap
890.2B782.3B682.37B694.27B614B
Enterprise value
867.79B773.33B672.24B692.05B619.67B
P/E ratio
62.24104.5734.677.739.62
Price to sales ratio
67.5766.3139.1751.1435.58
POCF ratio
246.07-69.2146.13-2.5K182.98
PFCF ratio
308.95-62.86380.38-144.3-80.19
P/B Ratio
13.7511.979.148.837.44
PTB ratio
13.7511.979.148.837.44
EV to sales
65.8765.5538.5950.9835.91
Enterprise value over EBITDA
183.14242.33106.37474.58168.44
EV to operating cash flow
239.88-68.41143.96-2.49K184.66
EV to free cash flow
301.18-62.13374.73-143.83-80.93
Earnings yield
000.0100.01
Free cash flow yield
0-0.020-0.01-0.01
Debt to equity
00000
Debt to assets
0.340.320.280.270.27
Net debt to EBITDA
-4.73-2.81-1.6-1.521.54
Current ratio
2.582.673.073.072.67
Interest coverage
4.47-0.776.61-1.77-3.71
Income quality
1.01-6.040.95-0.120.87
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.010.010.020.03
Research and developement to revenue
0.090.30.090.130.08
Intangibles to total assets
0.080.070.060.060.05
Capex to operating cash flow
-0.20.1-0.6216.32-3.28
Capex to revenue
-0.06-0.1-0.17-0.33-0.64
Capex to depreciation
-1.83-2.03-4.45-21.2-18.04
Stock based compensation to revenue
00000
Graham number
1.2K874.791.51K1.04K1.42K
ROIC
0.05-0.010.060.020.03
Return on tangible assets
0.040.020.050.020.04
Graham Net
346.36237.34282.98236.78103.38
Working capital
42.42B41.58B48.36B48.07B41.59B
Tangible asset value
57.12B59.12B68.47B72.39B76.29B
Net current asset value
36.23B36.06B42.77B42.31B35.69B
Invested capital
0.250.260.240.240.24
Average receivables
00000
Average payables
2B1.58B2.11B2.33B2.8B
Average inventory
12.82B16.32B15.54B15.74B16.35B
Days sales outstanding
00000
Days payables outstanding
21.9812.1418.5325.8626.38
Days of inventory on hand
130.84244.79149.54174.87136.51
Receivables turnover
00000
Payables turnover
4.17.414.863.483.41
Inventory turnover
0.690.370.60.510.66
ROE
0.060.030.070.030.05
Capex per share
-12.28-19.03-47.83-75.1-184.74

005690.KS Frequently Asked Questions

What is Pharmicell Co., Ltd. stock symbol ?

Pharmicell Co., Ltd. is a KR stock and trading under the symbol 005690.KS

What is Pharmicell Co., Ltd. stock quote today ?

Pharmicell Co., Ltd. stock price is $10600 today.

Is Pharmicell Co., Ltd. stock public?

Yes, Pharmicell Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs